A new experimental diabetes implant is drawing attention for its potential to automate insulin management and reduce the daily burden on patients. The technology relies on bioengineered insulin-producing cells protected by a microscopic crystalline-like shield, allowing them to function safely inside the body. One of its most distinctive aspects is that it works without external batteries, electronics, or constant manual input. Rather than operating like traditional medical devices, the implant […]